Viral Clearance Market Growth

Viral clearance market growth is anticipated at a CAGR of 10% during the period 2023-2035

 

According to a recently published report by Roots Analysis, increasing consumer demand for efficient production of contaminant-free biologics is driving the viral clearance market growth

Viral Clearance Industry Overview

The global viral clearance market is anticipated to grow at a CAGR of 10% from 2023-2035, reaching USD 1.7 billion by 2035.

Viral clearance testing plays a crucial role in ensuring the safety of biopharmaceutical products for human use by detecting and eliminating viral contaminants. With over 630 biologics approved by the FDA and more than 8,000 in clinical evaluation, the demand for viral clearance testing has surged in the biopharmaceutical industry. This testing is essential for regulatory approvals and has become a key prerequisite in the approval process. The complexity, cost, and time intensity of virus removal, viral inactivation, and virus detection have led to a growing trend of outsourcing these studies to specialized service providers with FDA-accredited laboratories. This strategic move allows biopharmaceutical manufacturers to navigate the challenges associated with viral clearance more efficiently. As a result, numerous service providers worldwide are actively involved in delivering proficient viral clearance testing services throughout the research and development stages. The increasing number of biopharmaceutical approvals and ongoing clinical trials underscore the significance of viral clearance testing in maintaining the integrity and safety of biopharmaceutical products in the market.

Browse 75+ figures and 100+ market data tables spread across 135+ pages and detailed Table of Content on “Viral Clearance Marke by Scale of Operation, Method of Viral Clearance Testing, End User and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035” here: https://www.rootsanalysis.com/reports/viral-clearance-and-testing-services-market.html

Market Drivers

Over the years, various factors have been recognized that are responsible for driving the viral clearance market size. One such factor is stringent regulatory guidelines. The presence of contaminants in biotherapeutics poses a great risk to the patients. Contaminants may cause various types of infectious diseases that are communicable. Owing to which, various regulatory bodies have introduced stringent regulatory guidelines for the approval of biopharmaceuticals. In order to comply with the regulatory guidelines more advanced techniques for viral clearance was demanded responsible for driving the demand for viral clearance market size.

Market Restraints

Market restraints in the viral clearance market stem from the intricate and time-intensive nature of viral clearance testing processes, leading to higher costs and prolonged timelines. The lack of specialized expertise required for virus removal and detection poses challenges, contributing to the overall complexity. Additionally, the COVID-19 pandemic has disrupted supply chains and impacted research activities, causing delays in the market. Limited awareness among smaller biopharmaceutical companies about the significance of viral clearance testing further constrains the market growth. These restraints collectively impede the seamless progression of the viral clearance market, requiring strategic solutions to overcome these challenges.

Growth Factors

Despite the current dominance of viral removal in the viral clearance testing services market, the sector is witnessing sustained growth due to ongoing innovations in techniques like chromatography, filtration, and precipitation. Viral inactivation, involving the use of physical or chemical methods, is also gaining traction. Laboratory supply companies are actively developing new mediums and reagents to enhance viral inactivation methods. Furthermore, the increasing presence of biologics, including cell and gene therapy, tissue and tissue products, and vaccines, in the market and pipeline will further fuel the demand for viral inactivation services, contributing to the overall expansion of the viral clearance market.

Viral Clearance Market Segments

Based on scale of operation, the market is segmented into Discovery Phase, Preclinical Phase and Clinical Phase.

• The clinical segment led the market for viral clearance, capturing the largest revenue share of close to 60% in 2023.
• The preclinical segment is anticipated to show the highest market growth potential by growing at a CAGR of around 10% during the forecast period.

Based on method of viral clearance and testing, the market is segmented into Viral Detection, Viral Inactivation and Viral Removal.

• The viral removal segment led the market for  viral clearance, capturing the largest revenue share of around 55% in 2023.
• In fact, the viral removal segment is anticipated to show the highest market growth potential by growing at a CAGR of over 10% during the forecast period.

Based on end users, the market is segment into Biotechnology and Pharmaceutical Companies and Academic/Research Institutes.

• The biotechnology and pharmaceutical companies segment led the market for viral clearance, capturing the largest revenue share of more than 70% in 2023.
• In fact, the  biotechnology and pharmaceutical companies segment is anticipated to show the highest growth potential during the forecast period of around 10% annually.

Based on key geographical regions, the market is segmented into North America, Europe, Asia-Pacific and The Rest of The World.

• North America dominated the market for viral clearance and accounted for the largest revenue share of about 38% in 2023.
• In Europe, the market for viral clearance is anticipated to demonstrate lucrative growth during the forecast period.

Key Companies Profiled

The viral clearance market report also includes detailed profiles of key players (listed below) that offer viral clearance services:

• Charles River Laboratories
• Eurofins Scientific
• Microbac Laboratories
• Nelson Labs
• Pall
• Syngene International
• Texcell

You Can Download Free Sample PDF Copy of This Report At:
https://www.rootsanalysis.com/reports/viral-clearance-and-testing-services-market/request-sample.html

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

Contact Details

Gaurav Chaudhary
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com